Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

40.13 -0.57 (-1.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,297,706
Open	41.02
Bid (Size)	38.56 (400)
Ask (Size)	41.00 (400)
Prev. Close	40.70
Today's Range	39.42 - 41.36
52wk Range	32.99 - 117.33
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CORCEPT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Corcept Therapeutics Investors to Contact the Firm Regarding Ongoing Investigation

February 04, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

February 04, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Performance

YTD	+5.1%	+5.1%
1 Month	+14.8%	+14.8%
3 Month	-47.6%	-47.6%
6 Month	-43.1%	-43.1%
1 Year	-40.0%	-40.0%

More News

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

February 04, 2026

Via NewMediaWire

Corcept Therapeutics Inc (NASDAQ:CORT) Fits the Affordable Growth Profile ↗

January 23, 2026

Via Chartmill

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

February 04, 2026

Via TheNewswire.com

3 Profitable Stocks with Warning Signs

February 03, 2026

Via StockStory

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

February 03, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

February 03, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Corcept Therapeutics Incorporated – CORT

February 03, 2026

From Pomerantz LLP

Via GlobeNewswire

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

February 03, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

February 03, 2026

Via TheNewswire.com

CORT FRAUD INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to Potential Securities Violations

February 02, 2026

Via NewMediaWire

CORT FRAUD INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to Potential Securities Violations

February 02, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

February 02, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing

January 30, 2026

From Hagens Berman

Via Business Wire

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

January 30, 2026

Via NewMediaWire

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

January 30, 2026

Via TheNewswire.com

CORT Shares Plummet On FDA’s Drug Rejection Letter Reveal — Here’s What Retail Has To Say ↗

January 30, 2026

Via Stocktwits

Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Securities Class Action Investigation – CORT

January 30, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

January 30, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

What's going on in today's after hours session ↗

January 29, 2026

Via Chartmill

Corcept Therapeutics (CORT): A Deep Dive into the 43.7% Earnings Growth and the High-Stakes Pivot to Oncology

January 28, 2026

Via Finterra

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

January 28, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

January 27, 2026

From Pomerantz LLP

Via GlobeNewswire

2 Stocks Under $50 to Target This Week and 1 We Turn Down

January 26, 2026

Via StockStory

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 40.13

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 02/04/26 04:00 PM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.65B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.